Literature DB >> 10432303

cDNA cloning and characterization of guinea-pig leukotriene B4 receptor.

K Masuda1, T Yokomizo, T Izumi, T Shimizu.   

Abstract

The cDNA for leukotriene B(4) (LTB(4)) receptor (BLT) was cloned from a guinea-pig leucocyte cDNA library. The cloned receptor cDNA encodes 348 amino acid residues and shares 73% identity with the amino acid sequence of human BLT. Northern blot analysis showed the highest expression of the receptor mRNA in leucocytes, followed by lung and spleen. The membrane fractions of HEK-293 and Cos-7 cells transfected with the cDNA showed specific LTB(4)-binding activities, with K(d) values of 0.27 and 0.17 nM respectively. Xenopus laevis oocytes injected with the cRNA of guinea-pig BLT showed LTB(4)-induced Cl(-) currents, indicating that the cloned receptor is functional. LTB(4) is metabolized to 20-hydroxy-LTB(4) and then to 20-carboxy-LTB(4), a transformation considered as a major inactivation pathway of the compound. Using the cloned receptor, we analysed the agonistic effects of LTB(4) and these two metabolites. 20-Carboxy-LTB(4) is a much weaker agonist, with a K(d) value higher than that of LTB(4) by three orders of magnitude, corresponding to a much weaker chemotactic activity. Although 20-hydroxy-LTB(4) is as potent as LTB(4) in inhibiting [(3)H]LTB(4) binding and cAMP formation, it is less potent than LTB(4) in the mobilization of intracellular Ca(2+) and the chemotaxis of Chinese hamster ovary cells expressing the guinea-pig BLT. The present study demonstrated that although LTB(4) and 20-hydroxy-LTB(4) bind to the receptor with similar affinities, they do differ in activating intracellular signalling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432303      PMCID: PMC1220439     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis.

Authors:  T Yokomizo; T Izumi; K Chang; Y Takuwa; T Shimizu
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

Review 2.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

3.  Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells.

Authors:  M A Gimbrone; A F Brock; A I Schafer
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

4.  Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis.

Authors:  C N Serhan; A Radin; J E Smolen; H Korchak; B Samuelsson; G Weissmann
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

5.  Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by betagamma dimers released by activation of Galphai-coupled receptors.

Authors:  H Arai; C L Tsou; I F Charo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs.

Authors:  E R Neptune; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion.

Authors:  R L Hoover; M J Karnovsky; K F Austen; E J Corey; R A Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils.

Authors:  J Palmblad; H Gyllenhammar; J A Lindgren; C L Malmsten
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

9.  Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes.

Authors:  S Shak; I M Goldstein
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

10.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.

Authors:  A W Ford-Hutchinson; M A Bray; M V Doig; M E Shipley; M J Smith
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

View more
  5 in total

1.  An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury.

Authors:  E Noiri; T Yokomizo; A Nakao; T Izumi; T Fujita; S Kimura; T Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 2.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

3.  Cell-specific transcriptional regulation of human leukotriene B(4) receptor gene.

Authors:  K Kato; T Yokomizo; T Izumi; T Shimizu
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

4.  A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.

Authors:  T Yokomizo; K Kato; K Terawaki; T Izumi; T Shimizu
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

5.  A strategy to model nonmonotonic dose-response curve and estimate IC50.

Authors:  Hui Zhang; Jeanne Holden-Wiltse; Jiong Wang; Hua Liang
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.